Court Favors Abbott in Yeda's 20-Year Fight for Autoimmune Protein Patent

Tony Dutra

首页> 外文期刊>World intellectual property report >Court Favors Abbott in Yeda's 20-Year Fight for Autoimmune Protein Patent

【24h】

Court Favors Abbott in Yeda's 20-Year Fight for Autoimmune Protein Patent

机译：法院在雅达为自身免疫蛋白专利开展的20年抗争中对雅培（Abbott）表示支持

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

1. Patent on discovery of protein used to treat autoimmune diseases rightfully went to Abbott 2. Early patent application can be enough even if it discloses only partial amino acid sequence After a 20-year fight, Yeda Research & Development Co. is running out of appeals on a claim that it beat Abbott GmbH & Co. to inventing a protein used to treat autoimmune diseases. The U.S. Court of Appeals for the Federal Circuit affirmed Sept. 20 a chain of rulings that Abbott's discovery of the TBP-II protein could claim priority to a patent application filed in Germany nine days before Yeda filed for similar patent coverage in Israel (Yeda Research & Dev. Co. v. Abbott GmbH & Co., 2016 BL 308787, Fed. Cir., No. 2015-1662, 9/20/16).

机译：1.雅培合理地发现了用于治疗自身免疫性疾病的蛋白质的专利。2.即使仅披露了部分氨基酸序列，早期专利申请也足够了。经过20年的奋斗，Yeda Research＆Development Co.用尽了有人声称它击败了Abbott GmbH＆Co.发明了一种用于治疗自身免疫性疾病的蛋白质。美国联邦巡回上诉法院于9月20日确认一连串裁决，称雅培发现TBP-II蛋白可能要求Yeda在以色列提出类似专利保护的前九天在德国提交的专利申请（Yeda Research）＆Dev。Co. v。Abbott GmbH＆Co.，2016 BL 308787，Fed。Cir。，No. 2015-1662，9/20/16）。

著录项

来源
《World intellectual property report》 |2016年第10期|22-22|共1页
作者
Tony Dutra;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Double Patenting and Process Patents; Apparently, Oxford, U.K., Is Not in California; When Does the Two-Way Test for Obviousness Apply?; Illumina Sues for Infringement of Analytical Technology Patent; Ruling in Favor of Affymetrix Overturned; Abbott Ordered to Pay $1.67 Billion; BASF Sues Pioneer Hi-Bred for Unlawful Use of Technology; DuPont Countersues Monsanto; Beckman, Orchid, and Sequenom Suit Dropped [J] . Biotechnology Law Report . 2009,第4期

机译：双重专利和工艺专利；显然，英国牛津不在加利福尼亚；双向性显而易见性测试何时适用？ Illumina起诉分析技术专利侵权；有利于Affymetrix的裁决被推翻；雅培被命令支付16.7亿美元；巴斯夫因非法使用技术而起诉Pioneer Hi-Bred；杜邦反诉孟山都公司；贝克曼（Beckman），兰花和西贡（Sequenom）西装掉落
2. Federal Court Absolves Abbott of $1.7 Billion Patent Verdict [J] . David Belian, Molly Cohen Washington Drug Letter . 2011,第10期

机译：联邦法院解除雅培公司17亿美元的专利判决
3. Chinese Court Rules in Favor of Apple in Design Patents Case [J] . Edwin Chan World intellectual property report . 2017,第5期

机译：中国法院裁定苹果在外观设计专利案中胜诉
4. The Impact of the Recent U.S. Supreme Court Decisions and Proposed New U.S. Patent and Trademark Office Rules and Patent Reform Legislation on Patent Acquisition, Exploitation, Enforcement and Defense Strategies [C] . M.M. Zoltick, J.A. Hynds, D. V. Scaltrito Society of Vacuum Coaters Annual Technical Conference . 2008

机译：美国最高法院最近的裁决以及拟议的美国专利商标局新规则和专利改革立法对专利获取，利用，执行和防御策略的影响
5. The impact of court-ordered school district finance reforms on high school proficiency test scores in New Jersey's Abbott districts. [D] . Kaplan, Marnie B. 2011

机译：法院下令的学区财务改革对新泽西州雅培地区高中水平考试成绩的影响。
6. What Is Your Reasonable Expectation of Success in Obtaining Pharmaceutical or Biotechnology Patents Having Nonobvious Claimed Inventions That the Courts Will Uphold? An Overview of Obviousness Court Decisions [O] . Daniel J. Pereira, Stephen G. Kunin 2015

机译：您对成功获得法院将支持的具有显而易见的要求保护的发明的制药或生物技术专利有何合理的期望？显而易见的法院判决概述
7. Monoclonal patent: Hybritech versus Abbott [O] . Carol Ezzell 1986

机译：单克隆专利：Hybritech与雅培

Court Favors Abbott in Yeda's 20-Year Fight for Autoimmune Protein Patent

摘要

著录项

相似文献

相关主题

期刊订阅